Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S217
DOI: 10.1016/j.ijrobp.2026.06.461 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von S. Laroze und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Laroze, S., Loap, P., Vignon, M., Lopez, H., Bouscary, D., & Kirova, Y. (2026). Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics, 126(1), S217. https://doi.org/10.1016/j.ijrobp.2026.06.461
Vancouver
Laroze S, Loap P, Vignon M, Lopez H, Bouscary D, Kirova Y. Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S217. doi:10.1016/j.ijrobp.2026.06.461
BibTeX
@article{Laroze2026,
author = {Laroze, S. and Loap, P. and Vignon, M. and Lopez, H. and Bouscary, D. and Kirova, Y.M.},
title = {Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S217},
doi = {10.1016/j.ijrobp.2026.06.461}
}
EUVIMED